Our previous studies have shown knockdown of NSD2 in EK mutated B-ALL cell lines resulted in decreased proliferation, decreased clonal growth, and increased sensitivity to cytotoxic chemotherapeutic agents with no effect on NSD2 wildtype lines [5]. This evidence concerns the gene NSD2 and acute lymphoblastic leukemia.